This leadcontainspromotional content. Please helpimprove it by removingpromotional language and inappropriateexternal links, and by adding encyclopedic text written from aneutral point of view.(August 2021) (Learn how and when to remove this message)

Indegene Limited

Formerly	Indegene Lifesystems Private Limited (1998–2016) Indegene Private Limited (2016–2022)
Company type	Public
Traded as	NSE: INDGN BSE: 544172
Industry	Pharmaceuticalconsultancy[1]
Founded	1998; 27 years ago (1998)
Founders	Rajesh Nair Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor
Headquarters	Bangalore , India
Area served	Worldwide
Key people	Manish Gupta (CEO)[2]
Revenue	₹2,589 crore (US$300 million) (FY24)[3]
Operating income	₹584 crore (US$67 million) (FY24)[3]
Net income	₹336 crore (US$38 million) (FY24)[3]
Owners	N. S. Raghavan (24.4%) Carlyle Group (10.22%)[4] Brighton Park Capital (9.55%)
Number of employees	5,081 (March 2024)[3]
Website	www.indegene.com

Indegene Limited is an Indian company that provides research andcommercialization services tobiopharmaceutical andhealthcare enterprises.^[5][6][7] Based inBangalore, the company provides consulting inpharmaceutical marketing,clinical trials,pharmacovigilance,medical andregulatory affairs, andhealth informatics.^[8][9]

Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran.^[10] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States.^[11] In 2008, Medsn officially became Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, acontinuing medical education company based in the United States.^[7][12]

In 2009, Indegene signed amaster service agreement with six pharmaceutical companies.^[6][13] The following year, Indegene acquiredCanada-based Aptilon, amultichannel marketing firm, for $4 million.^[14] The company subsequently acquiredAtlanta-based Total Therapeutic Management in 2014.^[15]

In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million.^[16]

In February 2021,the Carlyle Group and Brighton Park Capital invested $200 million in Indegene.^[17] In August 2021, Indegene acquired Medical Marketing Economics (MME), an Americanmarket access andpricing strategy company, for $10 million.^[18]

Indegene wentpublic in May 2024 with aninitial public offering, raising₹1,842 crore (US$210 million). It listed on theBSE and theNSE.^[19][20]

Indegene has offices in India, the United States, theEuropean Union, andAsia-Pacific.^[21][12]

In 2011 and 2012,The Economic Times named Indegene one of the best companies to work for in the Professional Services industry.^[22]

• Companies based in Bengaluru
• Indian companies established in 1998
• 1998 establishments in Karnataka
• Health care companies established in 1998
• Companies listed on the National Stock Exchange of India
• Companies listed on the Bombay Stock Exchange
• 2024 initial public offerings
• The Carlyle Group companies

• Articles with short description
• Short description is different from Wikidata
• Articles with a promotional tone from August 2021
• All articles with a promotional tone
• Use dmy dates from August 2018
• Use Indian English from August 2018
• All Wikipedia articles written in Indian English